Smith & Nephew (SNN) Change in Account Payables (2023 - 2024)
Smith & Nephew (SNN) posted quarterly Change in Account Payables of -$91.0 million for Q4 2024, up 47.09% year-on-year from -$61.9 million in Q1 2024, and up 47.09% on a QoQ basis from -$172.0 million in Q4 2023.
Smith & Nephew (SNN) Change in Account Payables (2023 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Change in Account Payables for 2 consecutive years, with -$91.0 million the latest figure, recorded in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 56.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -91.00 Mn |
| Dec 31, 2024 | -91.00 Mn |
| Dec 31, 2023 | -172.00 Mn |
| Dec 31, 2023 | -172.00 Mn |